HC Wainwright & Co. Reiterates Buy on Chimerix, Maintains $11 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on Chimerix (NASDAQ:CMRX) and maintained an $11 price target.
August 04, 2023 | 3:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Chimerix's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $11.
The reiteration of a 'Buy' rating and maintained price target by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. This could potentially lead to an increase in the stock's demand and subsequently its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100